Filana Therapeutics Inc.

FLNA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.62

-$0.04 (-5.78%)

At close: Oct 30, 2026, 4:00 PM ET

$0.65

+$0.03 (+4.95%)

Pre-market: Nov 2, 2026, 7:51 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $30.05M

Enterprise Value $-52.63M

Beta -0.66

Average Volume 1.54M

Shares Outstanding (Diluted) 48.31M

Shares Change YoY 0%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US14817C1071

Price Performance

Price Change 1M -30.0%

Price Change 3M -38.6%

Price Change 6M -58.9%

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -14.3%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR -81.3%

Valuation

PE Ratio -0.71

Forward PE 15.67

PEG Ratio -0.01

Forward PEG 0.01

PS Ratio N/A

Forward PS N/A

PB Ratio 0.47

P/FCF Ratio -0.95

P/Adj. FCF Ratio -0.83

P/OCF Ratio -1.51

EV/Sales N/A

EV/EBIT 1.22

EV/EBITDA 1.25

EV/FCF 1.66

Earnings Yield -140.3%

FCF Yield -105.7%

Adj. FCF Yield -120.4%

Financial Health

Net Cash $82.68M

Total Debt $0

Cash & Short-Term Investments $82.68M

Total Assets $103.9M

Current Ratio 2.08

Quick Ratio 2.08

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -7.36

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -13.9%

Returns

Return on Assets -40.7%

Return on Equity -58.8%

Return on Invested Capital -72.1%

Return on Capital Employed -72.1%

Return on Tangible Assets -40.7%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 11.7%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y N/A

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y -13.8%

Revenue Growth Next 3Y N/A

Earnings Date Nov 2, 2026

EPS Estimate (next Q) -$0.24

EPS Growth Est (next Q) 11.4%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $0.00

Price Target Upside N/A

Cash Flow

Operating Cash Flow $-31.16M

Free Cash Flow $-31.76M

Adj. Free Cash Flow $-36.16M

FCF Per Share -$0.42

OCF Per Share -$0.41

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-910K

Operating Income $-45.97M

EBITDA $-42.03M

Net Income $-42.28M

EPS (Diluted) -$0.87

Revenue / Employee N/A

Profit / Employee $-2.23M

Employees 19